Summary
- Current Price
- As of today, FULC price is $3.85, up +0.26% on
- Current Price All-Time High
- FULC price is currently -88.37% below its historical high of $33.10 set on
- Market Cap
- FULC current market cap is $294M, down -21.07% year-over-year
- Revenue
- FULC current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for FULC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Fulcrum Therapeutics, Inc. |
| Ticker | NASDAQ: FULC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fulcrumtx.com |
| Employees | 45 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $3.85 | |
| Price, 1D Change | +0.26% | |
| $294M | ||
| - | ||
| - | ||
| 0.71 | ||
| $0.00 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.18 | ||
| EPS, 1Y Change | -653.28% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.18 | ||
| EPS Estimate | -$0.66 | N/A |
| EPS Est. Change | +44.42% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $3.85 | |
| Price Target | $3.50 | - |
| Price Tgt. Change | -9.09% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.14 | -$0.16 | -8.96% | |
| -$1.17 | -$1.18 | -0.88% | |
| -$0.66 | N/A | +44.42% | |
| -$0.49 | N/A | +58.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $80.47M | $80.00M | -0.59% | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $3.85 | |
| $7.33 | ||
| $3.74 | ||
| $5.96 | ||
| $4.01 | ||
| $0.02 | ||
| 0.71 | ||
| $0.11 | ||
| 51.91 | ||
| 7.71% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.18 | ||
| -$1.39M | ||
| - | ||
| -$84.77M | ||
| - | ||
| -$74.88M | ||
| - | ||
| -$83.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 27.40 | ||
| 27.40 | ||
| - | ||
| - | ||
| 8.29 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 0.95 | ||
| 0.23 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $349.00M | ||
| $352.31M | ||
| $366.28M | ||
| $357.48M | ||
| $17.28M | ||
| $13.05M | ||
| $6.44M | ||
| $2.40M | ||
| $1.59M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $74.88M | ||
| $83.38M | ||
| $1.39M | ||
| $0.00 | ||
| $1.39M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$60.07M | ||
| $30.72M | ||
| $168.67M | ||
| $314.00K | ||
| -$60.38M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Truist Securities | → | |
| Stifel | → | |
| Piper Sandler | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | ||
| Truist Securities | → | |
| B of A Securities | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with FULC
FAQ
- What is the ticker symbol for Fulcrum Therapeutics, Inc.?
- The ticker symbol for Fulcrum Therapeutics, Inc. is NASDAQ:FULC
- Does Fulcrum Therapeutics, Inc. pay dividends?
- No, Fulcrum Therapeutics, Inc. does not pay dividends
- What sector is Fulcrum Therapeutics, Inc. in?
- Fulcrum Therapeutics, Inc. is in the Healthcare sector
- What industry is Fulcrum Therapeutics, Inc. in?
- Fulcrum Therapeutics, Inc. is in the Biotechnology industry
- What country is Fulcrum Therapeutics, Inc. based in?
- Fulcrum Therapeutics, Inc. is headquartered in United States
- When did Fulcrum Therapeutics, Inc. go public?
- Fulcrum Therapeutics, Inc. initial public offering (IPO) was on July 18, 2019
- Is Fulcrum Therapeutics, Inc. in the S&P 500?
- No, Fulcrum Therapeutics, Inc. is not included in the S&P 500 index
- Is Fulcrum Therapeutics, Inc. in the NASDAQ 100?
- No, Fulcrum Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Fulcrum Therapeutics, Inc. in the Dow Jones?
- No, Fulcrum Therapeutics, Inc. is not included in the Dow Jones index
- When was Fulcrum Therapeutics, Inc. last earnings report?
- Fulcrum Therapeutics, Inc.'s most recent earnings report was on July 31, 2026
- When does Fulcrum Therapeutics, Inc. report earnings?
- The next expected earnings date for Fulcrum Therapeutics, Inc. is October 29, 2026
Data Sources & References
- FULC Official Website www.fulcrumtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1680581/000119312526065197/0001193125-26-065197-index.htm
- FULC Profile on Yahoo Finance finance.yahoo.com/quote/FULC
- FULC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fulc